Home › Compare › JSBL vs ABBV

JSBL vs ABBV: Dividend Comparison 2026

JSBL yields 38.46% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JSBL wins by $173.2K in total portfolio value
10 years
JSBL
JSBL
● Live price
38.46%
Share price
$5.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$213.1K
Annual income
$34,859.06
Full JSBL calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — JSBL vs ABBV

📍 JSBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJSBLABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JSBL + ABBV cover 4 of 12 months — good coverage

Jan
ABBV
Feb
—
Mar
—
Apr
ABBV
May
—
Jun
—
Jul
ABBV
Aug
—
Sep
—
Oct
ABBV
Nov
—
Dec
—
JSBL pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JSBL
Annual income on $10K today (after 15% tax)
$3,269.23/yr
After 10yr DRIP, annual income (after tax)
$29,630.20/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, JSBL beats the other by $28,648.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JSBL + ABBV for your $10,000?

JSBL: 50%ABBV: 50%
100% ABBV50/50100% JSBL
Portfolio after 10yr
$126.5K
Annual income
$18,006.75/yr
Blended yield
14.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

JSBL
No analyst data
Altman Z
6.2
Piotroski
2/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JSBL buys
0
ABBV buys
0
No recent congressional trades found for JSBL or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJSBLABBV
Forward yield38.46% ✓3.67%
Annual dividend / share$2.00$6.20 ✓
Payout ratio50% ✓58%
1-year div growth0%4.7% ✓
5-year div CAGR0%8.9% ✓
Portfolio after 10y$213.1K ✓$39.9K
Annual income after 10y$34,859.06 ✓$1,154.43
Total dividends collected$158.5K ✓$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JSBL vs ABBV ($10,000, DRIP)

YearJSBL PortfolioJSBL Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$14,546$3,846.15$11,520$399.75+$3.0K → JSBL
2$20,793$5,228.67$13,261$450.98+$7.5K → JSBL
3$29,234$6,985.18$15,255$508.41+$14.0K → JSBL
4$40,458$9,178.25$17,536$572.74+$22.9K → JSBL
5$55,162$11,871.34$20,145$644.78+$35.0K → JSBL
6$74,150$15,126.76$23,126$725.38+$51.0K → JSBL
7$98,344$19,003.53$26,532$815.52+$71.8K → JSBL
8$128,783$23,555.24$30,420$916.26+$98.4K → JSBL
9$166,626$28,828.07$34,855$1,028.80+$131.8K → JSBL
10$213,149$34,859.06$39,914$1,154.43+$173.2K → JSBL

JSBL vs ABBV: Complete Analysis 2026

JSBL — Stock

JS Beauty Land Network Technology Inc. engages in the retail and wholesale of jade stone-adorned jewelry and decorations in China. The company was incorporated in 2018 and is based in Yancheng, China.

Full JSBL Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this JSBL vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JSBL vs SCHDJSBL vs JEPIJSBL vs OJSBL vs KOJSBL vs MAINJSBL vs JNJJSBL vs MRKJSBL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.